678 filings
Page 2 of 34
DEFA14A
fhja3jgmdl le0kv
28 Jul 23
Additional proxy soliciting materials
4:35pm
8-K
vbt71kdtnw1i6uy
21 Jul 23
Departure of Directors or Certain Officers
4:15pm
8-K
4k7z0znez6v5nnd3l0e1
26 Jun 23
InspireMD Announces Completion of Enrollment in C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trial
8:25am
424B3
3ut1zv 4p
2 Jun 23
Prospectus supplement
4:15pm
EFFECT
y44xz9
2 Jun 23
Notice of effectiveness
12:15am
CORRESP
ypss8r s1zku0mxk0mpo
31 May 23
Correspondence with SEC
12:00am
D
guuxr5
30 May 23
$42.17 mm in equity / options / securities to be acquired, sold $42.17 mm, 18 investors
9:07am
UPLOAD
noabrg3id44zec4k rxl
30 May 23
Letter from SEC
12:00am
8-K
oc17j efbm
23 May 23
Regulation FD Disclosure
9:00am
S-8
w0nu6glcn56 yi
17 May 23
Registration of securities for employees
4:00pm
8-K
d4pm0gwkjrez cs
16 May 23
InspireMD Reports First Quarter 2023 Financial Results and Provides
9:00am
8-K
rf9j5izz95hkzqp1cb
15 May 23
InspireMD Announces Private Placement of Up to $113.6 Million
4:15pm
8-K
wll1a
30 Mar 23
InspireMD Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business Update
7:14am
8-K
dnsptimp
20 Mar 23
InspireMD Announces Promotion of Andrea Tommasoli to Chief Operating Officer
8:10am